Another study found that the incidence of irAEs was higher in patients with NSCLC who received PD-1/PD-L1 inhibitors plus chemotherapy compared to those who received PD-1/PD-L1 inhibitors alone [18]. Here, CD274 is linked to non-small cell lung carcinoma.